fda shortage tirzepatide news confirms is still over, gives compounders a grace period Tirzepatide is NO longer in – Mounjaro and Zepbound Are No – FDA says shortage of GLP-1

The obtained aliquot poured into Cryovials and stored at -80C

A prospective study of dietary carotenoids, vitamins C and E, and risk of cataract in women

Stang A

Semaglutide, other obesity drugs show potential to treat nondiabetic stroke GLP-1 receptor agonists such as semaglutide may be able to help reduce the risk of ischemic stroke in patients without diabetes, according to a new meta-analysis of preclinical studies published in Stroke .[1] These drugs have been linked to several key improvements in the cardiovascular health of patients with type 2 diabetes

Demand transparent ingredients and realistic endpoints